Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedNov 11, 2020Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mgFailed Dissolution SpecificationZydus Pharmaceuticals (USA) Inc · D-0074-2021Class IIOngoingNov 11, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelNostrum Laboratories Inc · D-0068-2021Class IIOngoingNov 11, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelNostrum Laboratories Inc · D-0067-2021Class IIITerminatedNov 11, 2020Olanzapine Orally Disintegrating TabletsSubpotentJubilant Cadista Pharmaceuticals, Inc. · D-0066-2021Class IIITerminatedNov 11, 2020Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Reliever/Fever ReducerLabeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.Aurobindo Pharma USA Inc. · D-0065-2021Class IIITerminatedNov 11, 2020Fluocinonide Ointment USP 0.05%Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.Teligent Pharma, Inc. · D-0064-2021Class IITerminatedNov 11, 2020Time-Cap LabsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelMarksans Pharma Limited · D-0062-2021Class IITerminatedNov 11, 2020Time-Cap LabsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelMarksans Pharma Limited · D-0061-2021Class IITerminatedNov 11, 2020metformin HCL ER 750 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)PD-Rx Pharmaceuticals, Inc. · D-0060-2021Class IITerminatedNov 11, 2020metformin HCL ER 500 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)PD-Rx Pharmaceuticals, Inc. · D-0059-2021Class IITerminatedNov 11, 2020Metformin HCL E/R 500 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)Direct Rx · D-0058-2021Class IIOngoingNov 11, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)Denton Pharma, Inc. · D-0057-2021Class IIOngoingNov 11, 2020Metformin Hydrochloride Extended-Release Tablets USP 750 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)Denton Pharma, Inc. · D-0056-2021Class IITerminatedNov 11, 2020Chlorhexidine Gluconate 20% 0012 MedichemDiscoloration.Medichem S.A. · D-0055-2021Class IITerminatedNov 4, 2020N-A-C (N-Acetyl-L-CysteineMislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.Jarrow Formulas Inc · D-0302-2021Class IITerminatedNov 4, 2020Hydrocortisone butyrate CreamSUBPOTENT DRUGBausch Health Companies, Inc. · D-0054-2021Class IITerminatedNov 4, 2020CatapresAn extraneous peak was observed for dissolution testing.Boehringer Ingelheim Pharmaceuticals, Inc. · D-0053-2021Class IITerminatedNov 4, 2020CatapresAn extraneous peak was observed for dissolution testing.Boehringer Ingelheim Pharmaceuticals, Inc. · D-0052-2021Class IITerminatedNov 4, 2020CatapresAn extraneous peak was observed for dissolution testing.Boehringer Ingelheim Pharmaceuticals, Inc. · D-0051-2021Class IITerminatedNov 4, 2020Metformin Hydrochloride Extended Release 750 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)RemedyRepack Inc. · D-0050-2021Class IIITerminatedOct 28, 2020Candesartan Cilexetil and Hydrochlorothiazide TabletsOut-of-specification organic impurity results obtained during routine stability testing.Mylan Pharmaceuticals Inc. · D-0049-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0048-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0047-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0046-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0045-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0044-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0043-2021Class IIITerminatedOct 28, 2020DesfluraneDEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.eVenus Pharmaceutical Laboratories · D-0042-2021Class IIOngoingOct 28, 2020Killz Germz Hand SanitizerSub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.Genesis Partnership Company SA · D-0041-2021Class IIOngoingOct 28, 2020Killz Germz Hand SanitizerSub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.Genesis Partnership Company SA · D-0040-2021Class IIOngoingOct 28, 2020Genesis Hand Sanitizer GelCGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.Genesis Partnership Company SA · D-0039-2021Class IIOngoingOct 28, 2020Genesis Hand Sanitizer GelCGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.Genesis Partnership Company SA · D-0038-2021Class IIOngoingOct 28, 2020Panagel Hand SanitizerCGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.Genesis Partnership Company SA · D-0037-2021Class ITerminatedOct 28, 2020NP Thyroid 120Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.Acella Pharmaceuticals, LLC · D-0036-2021Class ITerminatedOct 28, 2020NP Thyroid 15Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.Acella Pharmaceuticals, LLC · D-0035-2021Class ITerminatedOct 21, 2020Smart Care HAND SANITIZERLabeling: Not Elsewhere Classified. Container packaging is made, formed or filled to be misleading, resembling food and drink pouchesAshtel Studios, Inc. · D-0098-2021Class IIITerminatedOct 21, 2020CystaranSubpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.Leadiant Biosciences, Inc. · D-0034-2021Class IIITerminatedOct 14, 2020NYSTATIN ORAL SUSPENSIONFailed Impurties/Degradation Specifications: out of specification results for an impurity for one lotVistaPharm, Inc. · D-0019-2021Class IITerminatedOct 14, 2020Losartan Potassium 100 mgCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level...Direct Rx · D-0018-2021Class IITerminatedOct 14, 2020Ranitidine 300 mgCGMP Deviations: Presence of NDMA impurity detected in product.Direct Rx · D-0017-2021